IMMU: Why This Biotech Could Go Crazy In 2019
August 28, 2018 at 17:30 PM EDT
It’s been a year of rapid-fire growth for IMMU. The stock has rocketed 51% in 2018 alone; and 103% in year-over-year growth. Momentum doesn’t seem to be trailing for the mid-cap company either.
